Advertisement
Screener

Canopy Growth Corp (CGC) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

Canopy Growth Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

Canopy Growth Corp (CGC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of 3.64 CAD/shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-08-07

  • Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2026-06-30 was 3.64 CAD/shares, a 93.24% decline year-over-year.
  • Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2025-06-30 was 53.84 CAD/shares.
  • Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2026 was 28.94 CAD/shares, a 91.35% decline from fiscal 2025.
  • Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2025 was 334.48 CAD/shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month
2026-06-303.64 CAD/shares
10-Q · filed 2026-08-07
2026-03-3128.94 CAD/shares
10-K · filed 2026-06-15
2025-12-3129.40 CAD/shares
10-Q · filed 2026-02-06
2025-09-3033.22 CAD/shares
10-Q · filed 2025-11-07
2025-06-3053.84 CAD/shares
10-Q · filed 2025-08-08
2025-03-31334.48 CAD/shares
10-K · filed 2025-05-30
2024-12-31226.05 CAD/shares
10-Q · filed 2025-02-07
2024-09-30319.28 CAD/shares
10-Q · filed 2024-11-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87